Pharmaceutical

Israeli company bags $4.2m contract to develop cell therapy for radiation poisoning

Pluri signed a 3-year contract to develop cell therapy to treat acute radiation syndrome in collaboration with the US Army.

Jul 11, 2023 - 20:00
Israeli company bags $4.2m contract to develop cell therapy for radiation poisoning
Pluri signed a 3-year contract to develop cell therapy to treat acute radiation syndrome in collaboration with the US Army.
Read the original article

Tags:

Previous Article

Covid-19: Anti-inflammatory drugs do not lead to a swifter hospital exit

Next Article

Roche’s Columvi receives marketing approval in Europe

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

Routine screening for kidney disease would be cost-effective, study argues

Routine screening for kidney disease would be cost-effe...

May 23, 2023

Treating Rural America: The new country doctors

Treating Rural America: The new country doctors

Oct 12, 2023

STAT+: Narcan manufacturer aims to price over-the-counter kit under $50

STAT+: Narcan manufacturer aims to price over-the-count...

Apr 21, 2023